Lithium protects against oxidative stress-mediated cell death in α-synuclein-overexpressing in vitro and in vivo models of Parkinson's disease.
about
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderA new look at an old drug: neuroprotective effects and therapeutic potentials of lithium saltsX MARCKS the spot: myristoylated alanine-rich C kinase substrate in neuronal function and diseaseProtein degradation pathways in Parkinson's disease: curse or blessingAntidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyLithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model.Pharmacological maintenance of protein homeostasis could postpone age-related diseasePharmacological lifespan extension of invertebratesLysosomal impairment in Parkinson's disease.Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification.Wnt and lithium: a common destiny in the therapy of nervous system pathologies?Animal models of Parkinson's disease: a gateway to therapeutics?Epigenetics: An Emerging Framework for Advanced Practice Psychiatric Nursing.Potential application of lithium in Parkinson's and other neurodegenerative diseases.The combination of lithium and l-Dopa/Carbidopa reduces MPTP-induced abnormal involuntary movements (AIMs) via calpain-1 inhibition in a mouse model: Relevance for Parkinson׳s disease therapy.Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance to oxidative stress.Quantitative study of volumetric changes of cerebellum in male adult rat following lithium administration.Network analysis of neurodegenerative disease highlights a role of Toll-like receptor signaling.Investigating the protective effect of lithium against high glucose-induced neurotoxicity in PC12 cells: involvements of ROS, JNK and P38 MAPKs, and apoptotic mitochondria pathway.
P2860
Q24626017-332AF761-4941-4DD2-9EB0-8E60E3018B25Q26741164-689E9425-EFD9-4205-AB2D-3A8AED759B6AQ26777270-CF15565A-25C6-43D9-9748-38CA9B13741AQ27026029-9B1A4BC8-D24F-4E9E-AF75-CCF9DB7AD7B2Q28395248-69BDD0D3-D0D0-47F1-89E3-91B951E6C997Q34625750-821FD597-2BA3-4686-9DB3-A6201EEFA7DAQ35836401-FB895F6D-6DB6-486E-A4BB-86D3456F794FQ36553629-87586C5A-0C2F-4FE5-A3B6-2E148F7087D6Q37461364-5E112F2B-08D5-4B91-9186-1A63697BC225Q37548320-0BABF53F-D513-4201-A6E3-8EB2C586AB5CQ38113139-24519DA5-E724-438D-99EB-A4303F48F0ADQ38155480-A52FC441-D392-406F-BBE4-64B0E24BE0BAQ38422704-5DB2BCCE-0C05-4D05-B3D1-E0C03AAE4C33Q38636753-FB42FBB8-D7D5-4EB1-B526-64220BDF9638Q38859177-9A864D0E-C13E-4A08-9104-9A2FBEA88488Q39375961-2F1224CB-A70C-4940-94AC-43325502E616Q41144422-AC53B7B3-8DE5-4761-B3AE-02E3F0A067A8Q41855850-04543912-5BDE-495F-A5B0-67296C97122EQ46859465-11C972F2-B2E8-4D73-A211-4A92852FC312
P2860
Lithium protects against oxidative stress-mediated cell death in α-synuclein-overexpressing in vitro and in vivo models of Parkinson's disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Lithium protects against oxida ...... models of Parkinson's disease.
@en
type
label
Lithium protects against oxida ...... models of Parkinson's disease.
@en
prefLabel
Lithium protects against oxida ...... models of Parkinson's disease.
@en
P2093
P2860
P356
P1476
Lithium protects against oxida ...... models of Parkinson's disease.
@en
P2093
Anand Rane
Julie K Andersen
Stephanie Lussier
Yong-Hwan Kim
P2860
P304
P356
10.1002/JNR.22700
P577
2011-06-24T00:00:00Z